Injective (INJ) has recently piqued investor interest as on-chain developments continue to evolve on the platform. These new integrations and valuable information have excited investors, resulting in a price increase of over 21%. Continuous positive developments are expected to further guide INJ on a bullish path.
The platform announced a significant achievement in reducing block times to just 0.65 seconds, compared to other layer 1 blockchains like Near, BNB, and Ethereum. This advancement improves the on-chain user experience and attracts traditional financial institutions by offering fast transaction speeds.
Injective also integrated with Balance, a cross-chain DeFi platform, introducing assets like bnUSD and enabling overcollateralized loans. This development opens new opportunities for investors, offering flexible loan terms with low interest rates.
Currently, token momentum faces resistance at $0.39, trapping it in a narrow $0.36-$0.39 range. Although bullish, the token's correlation with Bitcoin might lead to a downward trajectory.
